Loading... Please wait...
Categories
New Products
-
$253.89 -
$67.49 -
$22.99 -
$856.49 -
$228.19
Our Newsletter
- Home
- Signaling Pathway
- BMP/TGF-beta
- ITDts | TGF-β pathway inhibitor
- Home
- Stem Cell related
- ITDts | TGF-β pathway inhibitor
Product Description
ITDts is a novel selective TGF-β pathway-selective inhibitor that inhibits TGF-β activity by selectively degrading the TGF-β2 receptor at the proteosome level. Racemic ITDts is 2-fold selective over the closely related Activin A signaling pathway. ITDts stimulates embryonic stem cells to differentiate into cardiomyocytes (IC50 0.7 µM) by degrading the receptor and inhibiting intracellular signaling. ITDts has been formulated as a salt to increase stability and improve water solubility (~0.1 mg/mL) for ease of handling. As a salt, ITDts is chemically and metabolically stable and is non-cytotoxic. ITDts can be used to study a wide range of biological questions in cellular processing and TGF-β signaling.
Technical information:
| Chemical Formula: | C27H26F3NO3 | |
| CAS #: | N/A | |
| Molecular Weight: | 469.50 | |
| Purity: | >98% | |
| Appearance: | Yellow solid | |
| Chemical Name: | methyl 2,7,7-trimethyl-5-oxo-4-(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate | |
| Solubility: | Up to 50 mM in DMSO |
Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.
Reference:
| 1. | Willems E, et al. Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell Stem Cell. 2012;11(2):242-52. PMID: 22862949 |
Other Information:
Product Specification (pdf)
MSDS (pdf)
